Zobrazeno 1 - 10
of 156
pro vyhledávání: '"A. Aihetaimujiang"'
Autor:
Wenhao Xu, Shiqi Ye, Wangrui Liu, Huaqi Guo, Linhui Zhang, Shiyin Wei, Aihetaimujiang Anwaier, Kun Chang, Guilherme Malafaia, Hailiang Zhang, Dingwei Ye, Gang Wei
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-21 (2024)
Abstract In recent years, the environmental health issue of microplastics has aroused an increasingly significant concern. Some studies suggested that exposure to polystyrene microplastics (PS-MPs) may lead to renal inflammation and oxidative stress
Externí odkaz:
https://doaj.org/article/ae6667fb1e5e4dc5a27b17b710079786
Autor:
Wenhao Xu, Jiahe Lu, Xi Tian, Shiqi Ye, Shiyin Wei, Jun Wang, Aihetaimujiang Anwaier, Yuanyuan Qu, Wangrui Liu, Kun Chang, Hailiang Zhang, Dingwei Ye
Publikováno v:
MedComm, Vol 5, Iss 1, Pp n/a-n/a (2024)
Abstract Tertiary lymphoid structures (TLS) are organized aggregates of immune cells that form under pathological conditions. However, the predictive value of TLS in clear cell renal cell carcinoma (ccRCC) for immunotherapies remains unclear. We comp
Externí odkaz:
https://doaj.org/article/d0a5a888682c4b349193ea594e0ba56d
Autor:
Aihetaimujiang Anwaier, Wenhao Xu, Wangrui Liu, Shiyin Wei, Xi Tian, Yuanyuan Qu, Jianfeng Yang, Hailiang Zhang, Dingwei Ye
Publikováno v:
Journal of the National Cancer Center, Vol 3, Iss 3, Pp 236-249 (2023)
Background: The tumor microenvironment (TME) performs a crucial function in the tumorigenesis and response to immunotherapies of clear cell renal cell carcinoma (ccRCC). However, a lack of recognized pre-clinical TME-based risk models poses a great c
Externí odkaz:
https://doaj.org/article/969129b739b1425c96d291d4984cd366
Autor:
Hailiang Zhang, Lin Bai, Xin-Qiang Wu, Xi Tian, Jinwen Feng, Xiaohui Wu, Guo-Hai Shi, Xiaoru Pei, Jiacheng Lyu, Guojian Yang, Yang Liu, Wenhao Xu, Aihetaimujiang Anwaier, Yu Zhu, Da-Long Cao, Fujiang Xu, Yue Wang, Hua-Lei Gan, Meng-Hong Sun, Jian-Yuan Zhao, Yuanyuan Qu, Dingwei Ye, Chen Ding
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-21 (2023)
Abstract The tyrosine kinase inhibitor (TKI) Sunitinib is one the therapies approved for advanced renal cell carcinoma. Here, we undertake proteogenomic profiling of 115 tumors from patients with clear cell renal cell carcinoma (ccRCC) undergoing Sun
Externí odkaz:
https://doaj.org/article/8ad4bac66f634f059938ad9349903086
Autor:
Anwaier, Aihetaimujiang, Che, Xiangxian, Shi, Lei, Tian, Xi, Ye, Shiqi, Xu, Wenhao, Zhu, Yu, Zhang, Hailiang, Ye, Dingwei
Publikováno v:
In Journal of the National Cancer Center June 2024
Publikováno v:
Journal of the National Cancer Center, Vol 3, Iss 2, Pp 100-105 (2023)
With the advancement of anticancer therapy, there is increasing interest in understanding the tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) play a pivotal role in the TME and have been the focus of much research in recent years.
Externí odkaz:
https://doaj.org/article/bd37e0bb025a47d09ef4a33af9709f4f
Autor:
Dingwei Ye, Yuhao Wu, Hailiang Zhang, Wenhao Xu, Jiahe Lu, Wang-Rui Liu, Aihetaimujiang Anwaier, Xi Tian, Jia-Qi Su, Yuan-Yuan Qu, Jianfeng Yang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 12 (2023)
Background Tertiary lymphoid structures (TLS) are organized aggregates of immune cells that develop postnatally in non-lymphoid tissues and are associated with pathological conditions. TLS typically comprise B-cell follicles containing and are encomp
Externí odkaz:
https://doaj.org/article/b2c7171775a24630ba809176bc398236
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Zhongguo aizheng zazhi, Vol 33, Iss 3, Pp 191-200 (2023)
Renal cell carcinoma (RCC) is one of the three major urinary system tumors. With the changes of lifestyle and the rise of obesity, hypertension and other diseases, the incidence of RCC is increasing. The onset of RCC is hidden, and RCC has strong het
Externí odkaz:
https://doaj.org/article/9225b53dc6634e75b998670590f15493
Autor:
Yue Wang, Xi Tian, Shu-Xuan Zhu, Wen-Hao Xu, Aihetaimujiang Anwaier, Jia-Qi Su, Hua-Lei Gan, Yuan-Yuan Qu, Jian-Yuan Zhao, Hai-Liang Zhang, Ding-Wei Ye
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-16 (2023)
Abstract Background Papillary renal cell carcinoma (PRCC) can be divided into type 1 (PRCC1) and type 2 (PRCC2) and PRCC2 share a more invasive phenotype and worse prognosis. This study aims to identify potential prognostic and therapeutic biomarkers
Externí odkaz:
https://doaj.org/article/f228ab93ead649508c9a11b0d5a11b73